373 related articles for article (PubMed ID: 29348170)
1. CRISPR RNA and anti-CRISPR protein binding to the
Hong S; Ka D; Yoon SJ; Suh N; Jeong M; Suh JY; Bae E
J Biol Chem; 2018 Feb; 293(8):2744-2754. PubMed ID: 29348170
[TBL] [Abstract][Full Text] [Related]
2. Structure Reveals a Mechanism of CRISPR-RNA-Guided Nuclease Recruitment and Anti-CRISPR Viral Mimicry.
Rollins MF; Chowdhury S; Carter J; Golden SM; Miettinen HM; Santiago-Frangos A; Faith D; Lawrence CM; Lander GC; Wiedenheft B
Mol Cell; 2019 Apr; 74(1):132-142.e5. PubMed ID: 30872121
[TBL] [Abstract][Full Text] [Related]
3. Structure Reveals Mechanisms of Viral Suppressors that Intercept a CRISPR RNA-Guided Surveillance Complex.
Chowdhury S; Carter J; Rollins MF; Golden SM; Jackson RN; Hoffmann C; Nosaka L; Bondy-Denomy J; Maxwell KL; Davidson AR; Fischer ER; Lander GC; Wiedenheft B
Cell; 2017 Mar; 169(1):47-57.e11. PubMed ID: 28340349
[TBL] [Abstract][Full Text] [Related]
4. A Type I-F Anti-CRISPR Protein Inhibits the CRISPR-Cas Surveillance Complex by ADP-Ribosylation.
Niu Y; Yang L; Gao T; Dong C; Zhang B; Yin P; Hopp AK; Li D; Gan R; Wang H; Liu X; Cao X; Xie Y; Meng X; Deng H; Zhang X; Ren J; Hottiger MO; Chen Z; Zhang Y; Liu X; Feng Y
Mol Cell; 2020 Nov; 80(3):512-524.e5. PubMed ID: 33049228
[TBL] [Abstract][Full Text] [Related]
5. The crystal structure of Cpf1 in complex with CRISPR RNA.
Dong D; Ren K; Qiu X; Zheng J; Guo M; Guan X; Liu H; Li N; Zhang B; Yang D; Ma C; Wang S; Wu D; Ma Y; Fan S; Wang J; Gao N; Huang Z
Nature; 2016 Apr; 532(7600):522-6. PubMed ID: 27096363
[TBL] [Abstract][Full Text] [Related]
6. Alternate binding modes of anti-CRISPR viral suppressors AcrF1/2 to Csy surveillance complex revealed by cryo-EM structures.
Peng R; Xu Y; Zhu T; Li N; Qi J; Chai Y; Wu M; Zhang X; Shi Y; Wang P; Wang J; Gao N; Gao GF
Cell Res; 2017 Jul; 27(7):853-864. PubMed ID: 28574055
[TBL] [Abstract][Full Text] [Related]
7. Molecular insights into DNA interference by CRISPR-associated nuclease-helicase Cas3.
Gong B; Shin M; Sun J; Jung CH; Bolt EL; van der Oost J; Kim JS
Proc Natl Acad Sci U S A; 2014 Nov; 111(46):16359-64. PubMed ID: 25368186
[TBL] [Abstract][Full Text] [Related]
8. The subtype I-F CRISPR-Cas system influences pathogenicity island retention in Pectobacterium atrosepticum via crRNA generation and Csy complex formation.
Richter C; Fineran PC
Biochem Soc Trans; 2013 Dec; 41(6):1468-74. PubMed ID: 24256239
[TBL] [Abstract][Full Text] [Related]
9. Type III-A CRISPR-Cas Csm Complexes: Assembly, Periodic RNA Cleavage, DNase Activity Regulation, and Autoimmunity.
Jia N; Mo CY; Wang C; Eng ET; Marraffini LA; Patel DJ
Mol Cell; 2019 Jan; 73(2):264-277.e5. PubMed ID: 30503773
[TBL] [Abstract][Full Text] [Related]
10. Interference activity of a minimal Type I CRISPR-Cas system from Shewanella putrefaciens.
Dwarakanath S; Brenzinger S; Gleditzsch D; Plagens A; Klingl A; Thormann K; Randau L
Nucleic Acids Res; 2015 Oct; 43(18):8913-23. PubMed ID: 26350210
[TBL] [Abstract][Full Text] [Related]
11. Structural Variation of Type I-F CRISPR RNA Guided DNA Surveillance.
Pausch P; Müller-Esparza H; Gleditzsch D; Altegoer F; Randau L; Bange G
Mol Cell; 2017 Aug; 67(4):622-632.e4. PubMed ID: 28781236
[TBL] [Abstract][Full Text] [Related]
12. The CRISPR-associated DNA-cleaving enzyme Cpf1 also processes precursor CRISPR RNA.
Fonfara I; Richter H; Bratovič M; Le Rhun A; Charpentier E
Nature; 2016 Apr; 532(7600):517-21. PubMed ID: 27096362
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of foreign DNA recognition by a CRISPR RNA-guided surveillance complex from Pseudomonas aeruginosa.
Rollins MF; Schuman JT; Paulus K; Bukhari HS; Wiedenheft B
Nucleic Acids Res; 2015 Feb; 43(4):2216-22. PubMed ID: 25662606
[TBL] [Abstract][Full Text] [Related]
14. Crystal Structures of Csm2 and Csm3 in the Type III-A CRISPR-Cas Effector Complex.
Takeshita D; Sato M; Inanaga H; Numata T
J Mol Biol; 2019 Feb; 431(4):748-763. PubMed ID: 30639408
[TBL] [Abstract][Full Text] [Related]
15. CRISPR RNA and anti-CRISPR protein binding to the
Hong S; Ka D; Yoon SJ; Suh N; Jeong M; Suh JY; Bae E
J Biol Chem; 2018 Jun; 293(24):9233. PubMed ID: 29907732
[No Abstract] [Full Text] [Related]
16. Inhibition Mechanism of an Anti-CRISPR Suppressor AcrIIA4 Targeting SpyCas9.
Yang H; Patel DJ
Mol Cell; 2017 Jul; 67(1):117-127.e5. PubMed ID: 28602637
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure of the Csm3-Csm4 subcomplex in the type III-A CRISPR-Cas interference complex.
Numata T; Inanaga H; Sato C; Osawa T
J Mol Biol; 2015 Jan; 427(2):259-73. PubMed ID: 25451598
[TBL] [Abstract][Full Text] [Related]
18. Crystal structure of the CRISPR-Cas RNA silencing Cmr complex bound to a target analog.
Osawa T; Inanaga H; Sato C; Numata T
Mol Cell; 2015 May; 58(3):418-30. PubMed ID: 25921071
[TBL] [Abstract][Full Text] [Related]
19. RNA Targeting by Functionally Orthogonal Type VI-A CRISPR-Cas Enzymes.
East-Seletsky A; O'Connell MR; Burstein D; Knott GJ; Doudna JA
Mol Cell; 2017 May; 66(3):373-383.e3. PubMed ID: 28475872
[TBL] [Abstract][Full Text] [Related]
20. Inhibition mechanisms of AcrF9, AcrF8, and AcrF6 against type I-F CRISPR-Cas complex revealed by cryo-EM.
Zhang K; Wang S; Li S; Zhu Y; Pintilie GD; Mou TC; Schmid MF; Huang Z; Chiu W
Proc Natl Acad Sci U S A; 2020 Mar; 117(13):7176-7182. PubMed ID: 32170016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
